InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Chanda Sanjay. Director active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 6 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €7k. Activity tracked since 15 March 2024. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Chanda Sanjay is a declarant linked to AN2 Therapeutics, Inc. The 6 filings on record, all included in the sampled filings, cover the period from 2024-03-18 to 2026-02-23. Across these recent filings, the reported sell volume is EUR 6685 and the modal transaction nature is Attribution.